[Effects of angiotension II and (Sar1, Ile8)-angiotensin II on renal function (author's transl)]. 1979

G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015059 1-Sarcosine-8-Isoleucine Angiotensin II An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR. 1-Sar-8-Ile Angiotensin II,1-(N-Methylglycine)-8-L-Isoleucine-Angiotensin II,Sarile,1 Sar 8 Ile Angiotensin II,1 Sarcosine 8 Isoleucine Angiotensin II,Angiotensin II, 1-Sar-8-Ile,Angiotensin II, 1-Sarcosine-8-Isoleucine

Related Publications

G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
January 1982, Nihon Jinzo Gakkai shi,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
January 1982, European journal of clinical pharmacology,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
January 1988, Acta physiologica et pharmacologica Bulgarica,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
May 1994, Nuclear medicine and biology,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
June 1992, American journal of clinical oncology,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
July 1981, Life sciences,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
October 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
November 1994, Neuroscience,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
January 1986, Clinical and experimental pharmacology & physiology,
G Nomura, and D Uno, and T Takabatake, and S Arai, and M Shimao, and M Takata, and N Hattori
July 1991, International journal of peptide and protein research,
Copied contents to your clipboard!